PETNET Solutions, a wholly-owned subsidiary of Siemens Medical Solutions USA, Inc., and a leader in radiopharmaceutical manufacturing and distribution, has announced the execution of a supply agreement with Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, to provide BMS747158 for PET imaging of cardiac perfusion as part of the Phase II and Phase III trials. PETNET Solutions/Siemens has previously supplied all of the clinical trial doses for the Lantheus Phase I study. BMS747158 is Lantheus’ novel fluorine 18-labeled Positron Emission Tomography (PET) tracer for myocardial perfusion imaging in subjects under rest and stress conditions.
PETNET Solutions is committed to advancing molecular imaging by support of clinical trials.
“Our agreement with Lantheus further emphasizes PETNET’s network as an attractive channel for novel PET agents,” said Tom Welch, chief executive officer of PETNET Solutions. “We are proud to be involved with BMS747158 as one of the many important R&D projects that Siemens is actively engaged in. As the leading supplier of PET biomarkers, PETNET has the experience required to support the commercialization of new products, such as the Lantheus agent.”
PETNET Solutions operates the largest PET radiopharmacy network with 52 radiopharmacies and distribution centers worldwide that manufacture and distribute PET biomarkers to hospitals, clinics, and research facilities for PET imaging.
The Siemens Healthcare Sector is one of the world’s largest suppliers to the healthcare industry. The company is a renowned medical solutions provider with core competence and innovative strength in diagnostic and therapeutic technologies as well as in knowledge engineering, including information technology and system integration. With its laboratory diagnostics acquisitions, Siemens Healthcare is the first integrated healthcare company, bringing together imaging and lab diagnostics, therapy, and healthcare information technology solutions, supplemented by consulting and support services. Siemens Healthcare delivers solutions across the entire continuum of care – from prevention and early detection, to diagnosis, therapy and care. Additionally, Siemens Healthcare is the global market leader in innovative hearing instruments. The company employs around 49,000 people worldwide and operates in 130 countries. In the fiscal year 2008 (Sept. 30), Siemens Healthcare reported sales of €11.2 billion, orders of €11.8 billion, and Sector profit of €1.2 billion. Further information can be found by visiting http://www.siemens.com/healthcare .